Literature DB >> 9866008

Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS.

E Hardy1, K S de Pádua, M J Osis, A L Jiménez, L J Zaneveld.   

Abstract

Vaginal formulations may have "dual" protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9866008     DOI: 10.1016/s0010-7824(98)00106-1

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

Review 1.  Improving topical microbicide applicators for use in resource-poor settings.

Authors:  Janet G Vail; Jessica A Cohen; Kimberly L Kelly
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.

Authors:  Margaret R Weeks; Katie E Mosack; Maryann Abbott; Laurie Novick Sylla; Barbara Valdes; Mary Prince
Journal:  Sex Transm Dis       Date:  2004-11       Impact factor: 2.830

3.  Predictors of using a microbicide-like product among adolescent girls.

Authors:  Mary B Short; Paul A Succop; Ana M Ugueto; Susan L Rosenthal
Journal:  J Adolesc Health       Date:  2007-07-20       Impact factor: 5.012

4.  High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.

Authors:  Katie E Mosack; Margaret R Weeks; Laurie Novick Sylla; Maryann Abbott
Journal:  Women Health       Date:  2005

5.  Preferred characteristics of vaginal microbicides in women with bacterial vaginosis.

Authors:  Robert L Cook; Julie S Downs; Jeanne Marrazzo; Galen E Switzer; Ozlem Tanriover; Harold Wiesenfeld; Pamela J Murray; Sharon L Hillier
Journal:  J Womens Health (Larchmt)       Date:  2009-08       Impact factor: 2.681

6.  What do portuguese women prefer regarding vaginal products? Results from a cross-sectional web-based survey.

Authors:  Rita Palmeira-de-Oliveira; Paulo Duarte; Ana Palmeira-de-Oliveira; José das Neves; Maria Helena Amaral; Luiza Breitenfeld; José Martinez-de-Oliveira
Journal:  Pharmaceutics       Date:  2014-10-21       Impact factor: 6.321

7.  Eliciting Preferences for HIV Prevention Technologies: A Systematic Review.

Authors:  S Wilson Beckham; Norah L Crossnohere; Margaret Gross; John F P Bridges
Journal:  Patient       Date:  2020-12-15       Impact factor: 3.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.